{
  "company": {
    "name": "Aptadel Therapeutics",
    "website": "https://aptadeltx.com/",
    "record": "https://startuphistory.org/c/aptadeltx.com"
  },
  "status": null,
  "history_since": "2021-08-02T13:40:47.000Z",
  "baseline": {
    "snapshot_id": "441fae5f9ebe5bf88bd837521afec6a275a010a523dc4894813f891054815f9e",
    "observed_at": "2021-08-02T13:40:47.000Z",
    "headline": null,
    "description": "Aptadel Therapeutics is a pre-clinical stage drug development biotech company based on RNA Aptamer technology for the treatment of cancer.",
    "evidence": "https://web.archive.org/web/20210802134047/https://aptadeltx.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T11:21:09.161Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-05T11:21:09.161Z",
      "variants": [
        {
          "headline": "Aptámeros de precisión para cánceres agresivos.",
          "subhead": "A biomedical company developing aptamer technologies for cancer treatment. Discover Aptadel TX’s innovative approach to targeted therapies.",
          "observed_at": "2026-09-14T22:37:04.000Z",
          "evidence": "https://web.archive.org/web/20260914223704/https://www.aptadeltx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Aptámeros de precisión para cánceres agresivos.",
          "subhead": "Empresa biomédica que desarrolla tecnologías de aptámeros para el tratamiento del cáncer. Descubre el innovador enfoque de Aptadel TX en terapias dirigidas.",
          "observed_at": "2026-11-05T11:21:09.161Z",
          "evidence": "https://www.aptadeltx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Aptámeros de precisión para cánceres agresivos.",
      "subhead": "Empresa biomédica que desarrolla tecnologías de aptámeros para el tratamiento del cáncer. Descubre el innovador enfoque de Aptadel TX en terapias dirigidas.",
      "from": "2026-09-14T22:37:04.000Z",
      "to": "2026-11-05T11:21:09.161Z",
      "captures": 2,
      "evidence": "https://www.aptadeltx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-09-14T22:37:04.000Z",
          "to": "2026-11-05T11:21:09.161Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-85fd6958ef45740245b11da91c3ec55cb8e4464eeec8405c0e5a7f3893f4e8ef:8f1c8a7480a063b68b8293dae650a8d5ea8594ae2a2d27b87f8799704fb5b1a7:headline:81feff83c76d58ef",
      "before_evidence": "https://web.archive.org/web/20260311233251/https://aptadeltx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Aptadel Therapeutics” to “Aptámeros de precisión para cánceres agresivos.”.",
      "between": {
        "from": "2026-03-11T23:32:51.000Z",
        "to": "2026-09-14T22:37:04.000Z"
      },
      "evidence": "https://web.archive.org/web/20260914223704/https://www.aptadeltx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Aptadel Therapeutics” company record, https://startuphistory.org/c/aptadeltx.com"
}